Yayın:
An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGülbaş, Zafer
dc.contributor.authorGülçin Günden
dc.contributor.authorEren Gündüz
dc.contributor.authorOlga Meltem Akay
dc.contributor.authorAbdülvahap Aslan
dc.contributor.authorHülya Özen
dc.contributor.authorOğuz Çilingir
dc.contributor.authorEbru Erzurumluoğlu Gökalp
dc.contributor.authorSinem Kocagil
dc.contributor.authorSevilhan Artan
dc.contributor.authorZafer Gülbaş
dc.contributor.authorBeyhan Durak Aras
dc.contributor.orcid0000-0003-0243-784X
dc.contributor.orcid0000-0003-1707-1764
dc.contributor.orcid0000-0002-6759-1939
dc.contributor.orcid0000-0003-4144-3732
dc.contributor.orcid0000-0002-5593-4164
dc.contributor.orcid0000-0002-1275-5174
dc.contributor.orcid0000-0003-2595-3919
dc.contributor.orcid0000-0001-7658-6309
dc.contributor.orcid0000-0002-4709-0627
dc.contributor.orcid0000-0003-1881-1912
dc.date.accessioned2025-11-13T11:01:37Z
dc.date.issued2021-01-01
dc.identifier.doihttps://doi.org/10.1159/000520242
dc.identifier.endpage487
dc.identifier.issn1424-859X
dc.identifier.issue10-11
dc.identifier.openalexW4200028922
dc.identifier.startpage479
dc.identifier.urihttps://hdl.handle.net/11421/5988
dc.identifier.urihttps://doi.org/10.1159/000520242
dc.identifier.volume161
dc.language.isoen
dc.relation.ispartofCytogenetic and Genome Research
dc.rightsrestrictedAccess
dc.subjectBiology
dc.subjectLoss of heterozygosity
dc.subjectSNP
dc.subjectSNP array
dc.subjectChronic lymphocytic leukemia
dc.subjectSingle-nucleotide polymorphism
dc.subjectInternal medicine
dc.subjectOncology
dc.subjectGenetics
dc.subjectLeukemia
dc.subjectGene
dc.subjectMedicine
dc.subjectGenotype
dc.subjectAllele
dc.subject.sdg14
dc.titleAn Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5058571002

Dosyalar

Koleksiyonlar

Publications